Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03693378 · ClinicalTrials.gov registry record
A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
A clinical trial, sponsored by Immunovia.
- Completed
- Registry status
- 1,349
- Enrollment target
NCT03693378 is a clinical trial that has completed, run by Immunovia. The registered enrollment target is 1,349 participants.
The verdict
NCT03693378 has completed, sponsored by Immunovia.
- COMPLETED
- Registry status
- 1,349 participants
- Enrollment target
Study Summary
PanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups. The goals of the study are to assess the performance and diagnostic accuracy of the IMMray™ PanCan-d test compared to standard-of-care imaging.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,349 participants |
| Start Date | 2016-01-19 |
| Est. Completion | 2021-11-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03693378
The ClinicalTrials.gov registry entry for NCT03693378 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Immunovia, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03693378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03693378 about?
NCT03693378 is a clinical study titled "A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups". PanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups. The goals of the study are to assess the performance and diagnostic accuracy of the IMMray™ PanCan-d test compared to standard-of-care imaging.
What is the current status of trial NCT03693378?
This trial is currently completed. The enrollment target is 1,349 participants. The study started on 2016-01-19. Estimated completion is 2021-11-12.
Who is sponsoring clinical trial NCT03693378?
This trial is sponsored by Immunovia, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.